GlassScriptPhysician profile
Pamela Twitty
NPI 1518167378
$3,882.23
in general payments reported to CMS, 2019-2025
45 companies · $495 in 2025
The $495 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $394 · 2021: $573 · 2022: $718 · 2023: $685 · 2024: $494 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,589 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,588.71 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $569.20 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $299.91 | 2023-2025 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $252.61 | 2019-2022 | |
| Hologic Sales and Service, LLC | $219.71 | 2021-2024 | Aptima, Thinprep 2000 Processor, Affirm Prone Biopsy System |
| Sage Therapeutics, LLC | $193.81 | 2021-2025 | Zurzuvae |
| Coopersurgical, INC. | $192.78 | 2019-2025 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $174.66 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $160.14 | 2021-2022 | |
| Myriad Women'S Health, INC. | $114.86 | 2023 | |
| Exeltis, USA INC. | $113.14 | 2019-2025 | Slynd |
| Intuitive Surgical, INC. | $112.95 | 2025 | |
| Evofem Biosciences, INC. | $108.98 | 2021-2022 | |
| Pfizer INC. | $105.00 | 2020-2024 | |
| Mayne Pharma Commercial LLC | $98.93 | 2022-2024 | |
| Gynesonics, INC. | $91.11 | 2022 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $84.91 | 2020-2023 | Injectafer |
| Mylan Pharmaceuticals INC. | $82.81 | 2019-2022 | |
| Exact Sciences Corporation | $73.54 | 2023-2025 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $69.16 | 2021-2024 | Twirla |
| Scynexis, INC. | $64.60 | 2022 | |
| Avion Pharmaceuticals | $56.79 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.46 | 2020-2021 | |
| Amag Pharmaceuticals, INC. | $45.35 | 2019 | |
| Covidien LP | $43.55 | 2019 | |
| Ethicon US, LLC | $41.02 | 2024 | Enseal |
| Meditrina | $38.69 | 2023-2025 | |
| Vertical Pharmaceuticals, LLC | $38.04 | 2019 | |
| Minerva Surgical, INC | $36.84 | 2019-2021 | |
| Millicent US INC | $35.62 | 2019-2024 | Intrarosa |
| Boston Scientific Corporation | $35.14 | 2019-2021 | |
| Shield Therapeutics INC | $31.67 | 2023-2024 | Accrufer |
| Baxter Healthcare | $27.36 | 2023 | Adept |
| Angiodynamics, INC. | $21.97 | 2019 | |
| Karl Storz Endoscopy-America | $21.92 | 2024 | |
| Conmed Corporation | $20.94 | 2025 | Airseal |
| Channel Medsystems, INC. | $20.35 | 2023 | |
| Lilly USA, LLC | $19.96 | 2025 | Zepbound, Mounjaro |
| Amgen INC. | $17.83 | 2019 | |
| Organon LLC | $17.41 | 2023 | Nexplanon |
| Becton, Dickinson and Company | $15.62 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $15.58 | 2023 | Exparel |
| Mycovia Pharmaceuticals, INC. | $14.96 | 2022 | |
| Smith+Nephew, INC. | $13.89 | 2024 | Pico 14 |
| Merck Sharp & Dohme LLC | $12.94 | 2019 | |
| Molnlycke Health Care US, LLC | $10.52 | 2023 | Mepilex Border Post-Op, Mepilex Border Post-Op Ag, Mepilex Border Flex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Twitty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.